إعلان
إعلان
INCY
Incyte Genomics Inc
110.61
USDبرعاية
+3.95
+3.71%
٠٧ يناير, ١٦:٠٠ UTC -5
مغلق
بعد الإغلاق
111.58
+0.96
+0.87%
تقارير أرباح INCY
النسبة الإيجابية المفاجئة
INCY تفوق 20 من 39 آخر التقديرات.
51%
التقرير التالي
بيانات التقرير القادم
٠٩ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$1.38B
/$1.95
التغير الضمني من Q3 25 (Revenue/ EPS)
+0.81%
/-13.33%
التغير الضمني من Q4 24 (Revenue/ EPS)
+16.83%
/+36.36%
Incyte Genomics Inc earnings per share and revenue
On ٢٨ أكتوبر ٢٠٢٥, INCY reported earnings of 2.25 USD per share (EPS) for Q3 25, beating the estimate of 1.68 USD, resulting in a 33.74% surprise. Revenue reached 1.37 مليار, compared to an expected 1.28 مليار, with a 6.70% difference. The market reacted with a -1.54% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 25 المحللين forecast an EPS of 1.95 USD, with revenue projected to reach 1.38 مليار USD, implying an نقصان of -13.33% EPS, and زيادة of 0.81% in Revenue from the last quarter.
الأسئلة الشائعة
What were Incyte Genomics Inc's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Incyte Genomics Inc reported EPS of $2.25, beating estimates by 33.74%, and revenue of $1.37B, 6.7% above expectations.
How did the market react to Incyte Genomics Inc's Q3 2025 earnings?
The stock price moved down -1.54%, changed from $93.08 before the earnings release to $91.65 the day after.
When is Incyte Genomics Inc expected to report next?
The next earning report is scheduled for ٠٩ فبراير ٢٠٢٦.
What are the forecasts for Incyte Genomics Inc's next earnings report?
Based on 25
المحللين, Incyte Genomics Inc is expected to report EPS of $1.95 and revenue of $1.38B for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان